# Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

> **NCT03764683** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Bipolar Disorder
- Insomnia

## Interventions

- **DRUG:** Suvorexant (Belsomra)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03764683
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-02-26
- **Primary completion:** 2021-01-06
- **Final completion:** 2021-01-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was terminated due to COVID-19.
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764683, "Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03764683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*